Bumex and Sinusitis - chronic - a phase IV clinical study of FDA data

Summary:

Sinusitis - chronic is reported as a side effect among people who take Bumex (bumetanide), especially for people who are female, 60+ old, also take Solu-Medrol, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Sinusitis - chronic when taking Bumex. It is created by eHealthMe based on reports of 9,078 people who have side effects when taking Bumex from the FDA, and is updated regularly.

What is Bumex?

Bumex has active ingredients of bumetanide. It is often used in swelling. eHealthMe is studying from 9,210 Bumex users. Check the latest studies of Bumex.

What is Sinusitis - chronic?

Sinusitis - chronic is found to be associated with 1,000 drugs and 762 conditions by eHealthMe. Check the latest studies of Sinusitis - chronic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

9,078 people reported to have side effects when taking Bumex.
Among them, 11 people (0.12%) have Sinusitis - chronic.

Among these 11 people:

What is the gender of people who have Sinusitis - chronic when taking Bumex? *

female: 100 %
male: 0.0 %

What is the age of people who have Sinusitis - chronic when taking Bumex? *

What are other drugs people take besides Bumex? *

What are other side effects people have besides Sinusitis - chronic? *

Acute Kidney Failure: 11 people, 100.00%
Pneumonia: 10 people, 90.91%
Cardiac Failure Congestive: 9 people, 81.82%
Weakness: 9 people, 81.82%
Diarrhea: 9 people, 81.82%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 63.64%
Dyspnea (difficult or laboured breathing): 7 people, 63.64%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 7 people, 63.64%
Atelectasis (partial or complete collapse of the lung): 6 people, 54.55%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 6 people, 54.55%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 36.36%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Bumex and have Sinusitis - chronic?

- Check whether Sinusitis - chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bumex:

Bumex (9,210 reports)

Browse all side effects of Bumex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - chronic:

Sinusitis - chronic (1,000 drugs)

Browse all the conditions that are associated with Sinusitis - chronic:

Sinusitis - chronic (762 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumex) and Bumex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.